Astera Labs, Inc. (NASDAQ:ALAB) Given Average Rating of “Moderate Buy” by Brokerages

Astera Labs, Inc. (NASDAQ:ALAB) has received an average recommendation of “Moderate Buy” from the twenty-two research firms that are currently covering the stock, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation and fifteen have issued a buy recommendation on the company. The average 12-month price target among brokers that have covered the stock in the last year is $190.6316.

A number of research firms recently commented on ALAB. Needham & Company LLC lifted their price target on Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Citigroup reiterated an “outperform” rating on shares of Astera Labs in a research note on Tuesday, December 9th. Wall Street Zen lowered Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. BNP Paribas Exane began coverage on Astera Labs in a report on Thursday, November 20th. They set an “outperform” rating for the company. Finally, Royal Bank Of Canada assumed coverage on shares of Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price objective on the stock.

Insiders Place Their Bets

In other news, General Counsel Philip Mazzara sold 4,620 shares of the company’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the transaction, the general counsel owned 147,040 shares of the company’s stock, valued at approximately $21,275,217.60. This represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Manuel Alba sold 150,000 shares of the stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the transaction, the director owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This trade represents a 8.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 576,936 shares of company stock worth $87,409,540 in the last 90 days. Corporate insiders own 12.50% of the company’s stock.

Institutional Trading of Astera Labs

Several institutional investors have recently added to or reduced their stakes in the company. Perigon Wealth Management LLC lifted its holdings in shares of Astera Labs by 6.2% during the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after buying an additional 73 shares in the last quarter. Clearstead Advisors LLC increased its position in Astera Labs by 13.6% during the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after acquiring an additional 76 shares during the period. Sound Income Strategies LLC raised its stake in Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after purchasing an additional 76 shares in the last quarter. Venturi Wealth Management LLC raised its stake in Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after purchasing an additional 84 shares in the last quarter. Finally, Great Valley Advisor Group Inc. boosted its holdings in Astera Labs by 2.2% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after purchasing an additional 90 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Trading Down 3.8%

Shares of ALAB opened at $169.66 on Friday. The company’s fifty day simple moving average is $161.80 and its 200 day simple moving average is $169.34. Astera Labs has a 1-year low of $47.13 and a 1-year high of $262.90. The company has a market cap of $28.66 billion, a price-to-earnings ratio of 152.85, a PEG ratio of 2.31 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The company had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company’s quarterly revenue was up 103.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, research analysts forecast that Astera Labs will post 0.34 earnings per share for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.